The study assesses drug trough levels, anti-drug antibody formation, and TNFα concentrations, and explores their correlation with clinical outcomes, including the clinical activity and relevant haematological and biochemical markers, among which are acute-phase proteins such as fibrinogen and C-reactive protein (CRP), given their close link to systemic and vascular inflammation in Crohn’s disease. Here, CRP is linked to Crohn disease.